Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chacko

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Hepatology Communications|October 24, 2024
Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitisAlvi Husni Islam, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionRobert J Fontana, Robert S Brown, Ana Moreno-Zamora, et al.
BMC Plant Biology|August 29, 2015
Genome sequencing of herb Tulsi (Ocimum tenuiflorum) unravels key genes behind its strong medicinal propertiesAtul K Upadhyay, Anita R Chacko, A Gandhimathi, et al.
Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Hepatology Communications|October 24, 2024
Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitisAlvi Husni Islam, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionRobert J Fontana, Robert S Brown, Ana Moreno-Zamora, et al.
BMC Plant Biology|August 29, 2015
Genome sequencing of herb Tulsi (Ocimum tenuiflorum) unravels key genes behind its strong medicinal propertiesAtul K Upadhyay, Anita R Chacko, A Gandhimathi, et al.
Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 11